Ashbita Pokharel

20 posts

Ashbita Pokharel

Ashbita Pokharel

@AshbitaP

Pathology resident Beaumont

Katılım Eylül 2020
58 Takip Edilen66 Takipçiler
Olabisi Afolayan-Oloye
Olabisi Afolayan-Oloye@Olabisi34638607·
I am excited to announce that I am officially board certified in Anatomic and Clinical Pathology! What a month this has been! I am grateful for all the support and mentorship and for everyone of my teachers. Looking forward to a great future. #pathtwitter
Olabisi Afolayan-Oloye tweet mediaOlabisi Afolayan-Oloye tweet media
English
79
43
904
37.3K
Mai Elzieny
Mai Elzieny@MaiElzieny·
My abstract got accepted ✔️ My friends’ abstracts got accepted ✔️ Winning USCAP travel award ✔️✔️✔️ It’s a great honor to be selected! Thanks to Dr. Kuhar, the whole committee,& USCAP. I’m over the moon! Can’t wait to meet everyone in NOLA! #USCAP
Mai Elzieny tweet media
English
13
3
74
10.6K
Ashbita Pokharel retweetledi
Mai Elzieny
Mai Elzieny@MaiElzieny·
Thanks #CAP22 for the wonderful organization & lovely memories. Thanks #PathTwitter family for being so supportive & incredible. I can’t wait for my next meeting to see all current & future pathology stars again!
Mai Elzieny tweet media
English
0
2
21
0
Ashbita Pokharel retweetledi
Beaumont, Royal Oak - Pathology Residency
And the answer is Fibrolamellar Carcinoma. Great job to everyone who replied! Rare primary liver tumor (1-5% of HCC) Single >10cm mass, often w/central scar Non-cirrhotic patients 10-35yrs (+)HepPar1, Arginase-1, CK7, as well as CD68. Characteristic fusion gene DNAJB1-PRKACA
Beaumont, Royal Oak - Pathology Residency tweet mediaBeaumont, Royal Oak - Pathology Residency tweet mediaBeaumont, Royal Oak - Pathology Residency tweet media
English
1
4
13
0